Olszewski U - Search Results

1

Caspase-cleaved cytokeratin 18 fragment (M30) as marker of postoperative residual tumor load in colon cancer patients.

Ausch C, Buxhofer-Ausch V, Olszewski U, Hinterberger W, Ogris E, Schiessel R, Hamilton G. Ausch C, et al. Among authors: olszewski u. Eur J Surg Oncol. 2009 Nov;35(11):1164-8. doi: 10.1016/j.ejso.2009.02.007. Epub 2009 Feb 28. Eur J Surg Oncol. 2009. PMID: 19254831

2

Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patients.

Ausch C, Buxhofer-Ausch V, Olszewski U, Schiessel R, Ogris E, Hinterberger W, Hamilton G. Ausch C, et al. Among authors: olszewski u. J Gastrointest Surg. 2009 Nov;13(11):2020-6. doi: 10.1007/s11605-009-0992-6. Epub 2009 Sep 2. J Gastrointest Surg. 2009. PMID: 19727975

3

Circulating cytokeratin 18 fragments and activation of dormant tumor cells in bone marrow of cancer patients.

Ausch C, Buxhofer-Ausch V, Olszewski U, Hamilton G. Ausch C, et al. Among authors: olszewski u. Exp Ther Med. 2010 Jan;1(1):9-12. doi: 10.3892/etm_00000002. Epub 2010 Jan 1. Exp Ther Med. 2010. PMID: 23136585 Free PMC article.

4

Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.

Olszewski U, Hamilton G. Olszewski U, et al. Mol Oncol. 2009 Jun;3(3):204-13. doi: 10.1016/j.molonc.2009.01.006. Epub 2009 Feb 3. Mol Oncol. 2009. PMID: 19393580 Free PMC article.

5

A better platinum-based anticancer drug yet to come?

Olszewski U, Hamilton G. Olszewski U, et al. Anticancer Agents Med Chem. 2010 May;10(4):293-301. doi: 10.2174/187152010791162306. Anticancer Agents Med Chem. 2010. PMID: 20187870 Review.

6

Mechanisms of cytotoxicity of anticancer titanocenes.

Olszewski U, Hamilton G. Olszewski U, et al. Anticancer Agents Med Chem. 2010 May;10(4):302-11. doi: 10.2174/187152010791162261. Anticancer Agents Med Chem. 2010. PMID: 20380637 Review.

7

Overexpression of CYP3A4 in a COLO 205 Colon Cancer Stem Cell Model in vitro.

Olszewski U, Liedauer R, Ausch C, Thalhammer T, Hamilton G. Olszewski U, et al. Cancers (Basel). 2011 Mar 22;3(1):1467-79. doi: 10.3390/cancers3011467. Cancers (Basel). 2011. PMID: 24212669 Free PMC article.

8

Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factors.

Ulsperger E, Hamilton G, Olszewski U, Baumgartner G, Engel A, Mallinger R. Ulsperger E, et al. Among authors: olszewski u. Oncol Rep. 2003 Sep-Oct;10(5):1529-34. Oncol Rep. 2003. PMID: 12883736

9

In vitro cytotoxicity of novel platinum-based drugs and dichloroacetate against lung carcinoid cell lines.

Fiebiger W, Olszewski U, Ulsperger E, Geissler K, Hamilton G. Fiebiger W, et al. Among authors: olszewski u. Clin Transl Oncol. 2011 Jan;13(1):43-9. doi: 10.1007/s12094-011-0615-z. Clin Transl Oncol. 2011. PMID: 21239354

10

Genome-wide gene expression analysis of chemoresistant pulmonary carcinoid cells.

Olszewski U, Zeillinger R, Geissler K, Hamilton G. Olszewski U, et al. Lung Cancer (Auckl). 2010 Sep 4;1:107-117. doi: 10.2147/LCTT.S12874. eCollection 2010. Lung Cancer (Auckl). 2010. PMID: 28210111 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters